Navigation Links
Sigma-Aldrich(R) Becomes First Life Science Company to Publish in PubMed's Peer-Reviewed Video Journal JoVE

ST. LOUIS, Sept. 17 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) today announced the publication of its first peer-reviewed video protocol in the PubMed accessible Journal of Visualized Experiments (JoVE). This makes Sigma-Aldrich the first life science company to submit a video protocol to the traditional scientific publication process. Peer-reviewed video protocols are an innovative and highly effective tool to increase the efficiency of scientific communication and with it the speed of basic research and drug discovery (

"Producing peer reviewed resources and making them available in locations that researchers trust is an invaluable tool for the research community," said John Custer, Marketing Manager-Biochemistry for Sigma-Aldrich. "We look forward to hearing our customers' feedback while we continue working on additional video protocols."

Less than two years old, JoVE is a scientific journal that publishes video articles of biological experiments from leading academic institutions including Harvard, MIT, Stanford, and Berkeley. JoVE recently became the first and only video-based scientific journal to be indexed in MEDLINE and PubMed, the official repositories of the National Library of Medicine (NLM) at the National Institute of Health (NIH).

"Scientists depend on fast access to high quality information both from other scientists and increasingly from industry. The fact that an industry leader dedicates its resources to make its scientific knowledge accessible using the most innovative forms of scientific communication will strongly benefit the scientific community," said Klaus Korak, co-founder of JoVE.

The first video protocol titled, Sigma's Non-Specific Protease Activity Assay -- Casein as a Substrate, is a multipurpose protease assay employed by life science researchers in academia, biotech, and pharmaceutical industry. The video protocol can be viewed on JoVE and the Sigma Aldrich website and is available in both English and Chinese. Sigma Aldrich plans to continue creating video protocols spanning many different topics of scientific research.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 36 countries and has 8,000 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit our award-winning website at

About JoVE: JoVE is the first-and-only video-based scientific journal indexed in MEDLINE and PubMed. JoVE was founded in October 2006 as the first online journal devoted to video-publication of life science research. This novel, dynamic, and visual approach to scientific publishing aims to increase the reproducibility of published studies and to improve the efficiency of research in the biological sciences. JoVE has assembled an Editorial Board that includes 24 scientists from Harvard, Princeton, NIH, and other leading institutions across the US, Europe, and Japan. JoVE has so far released 19 monthly issues including over 230 video protocols on experimental approaches in developmental biology, neuroscience, microbiology and other fields. To facilitate the integration of video content into scientific publishing, JoVE has developed an organizational and technical infrastructure to perform and/or assist scientists with filming and editing in their labs. For more information please contact:

SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
2. Haemonetics Becomes Preferred Provider of Plasma Collection Products to Octapharma Europe
3. Prof. Michel Klein Becomes Chief Scientific Officer at AMVAC
4. REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide
5. Bioheart Founder, Howard J. Leonhardt, Becomes Chairman of the Board of Directors
6. SURGEX(TM) Becomes the Official Sports Nutrition Drink of Former NBA Player Dee Brown and his Edge Basketball Training Facility
7. Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing
8. Yale Keck Microarray Center Becomes a GeneGo Center of Excellence
9. 18-Month Extension of Reimbursement Rates for Radioimmunotherapies Becomes Law After Congressional Override of Presidential Veto
10. University of Miami Miller School of Medicine Becomes a GeneGo Center of Excellence
11. Truman Medical Centers Becomes One of the First Hospitals in the U.S. To Install the Worlds First Adaptive 128-slice CT Scanner
Post Your Comments:
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is one ... biomarkers market with pharmaceutical companies and diagnostic ... diagnostic tests. . ... Complete report on global cancer biomarkers market ...
(Date:11/25/2015)... 26, 2015 --> ... 2016 - 2020 report analyzes that automating biobanking ... quality in long-term samples, minimizing manual errors, improving ... minimizes manual errors such as mislabeling or inaccurate ... it plays a vital role in blood fractionation, ...
(Date:11/25/2015)... , November 25, 2015 ... cat and human plaque and pave the way for more ... problems in cats     --> ... most commonly diagnosed health problems in cats, yet relatively little ... now. Two collaborative studies have been conducted by researchers from ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
Breaking Biology Technology:
(Date:10/26/2015)... Calif. and LAS VEGAS ... Nok Nok Labs , an innovator in modern authentication ... , today announced the launch of its latest version ... unified platform enabling organizations to use standards-based authentication that ... Nok Nok S3 Authentication Suite is ideal for organizations ...
(Date:10/23/2015)... 23, 2015 Research and Markets ( ... Voice Recognition Biometrics Market 2015-2019" report to their ... The global voice recognition biometrics market to grow ... --> --> The report, ... based on an in-depth market analysis with inputs from ...
(Date:10/22/2015)... Mass., Oct. 22, 2015  Aware, Inc. (NASDAQ: AWRE ), ... results for its third quarter ended September 30, 2015.  ... quarter of 2015 was $4.0 million, a decrease of 33% compared ... in the third quarter of 2015 was $2.2 million, or $0.10 ... diluted share, in the same period a year ago.  ...
Breaking Biology News(10 mins):